Advanced Cell Technology news from FierceBiotech
News
High-flying Advanced Cell Technology crashes
One of the highest profile stem cell developers in the U.S. may be close to shutting down. The Boston Globe is reporting that in new SEC documents Advanced Cell Technology has said that it can't Read more...
FDA's delay of Geron ESC trial raises concerns
Getting an embryonic stem cell therapy through clinical trials in the U.S. is looking like an increasingly tough challenge after Geron announced that the FDA is delaying a study of its experimental Read more...
What's in store for stem cell treatments?
At yesterday's hearing on stem cells, the FDA set a high bar for the treatments, saying Read more...
Get more Advanced Cell Technology coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets